Modern Weight-Loss Therapy: Sustainable or Short-Lived?

Created using ChatSlide

A clinically grounded panel discussion on obesity as a chronic disease and the role of weight-loss medicines as part of sustainable, shared-care treatment. It examines current Australian options, GLP-1 and GIP therapies, landmark STEP and SURMOUNT evidence, benefits beyond weight reduction, tolerability, long-term safety and weight regain after discontinuation. The session also considers dose reduction, emerging agents and the risks of poorly evidenced supplements, concluding with practical...